TrialThe Journal of infectious diseases2022

Safety and Pharmacokinetics of Monoclonal Antibodies VRC07-523LS and PGT121 Administered Subcutaneously for Human Immunodeficiency Virus Prevention.

Sharana Mahomed et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.